These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


PUBMED FOR HANDHELDS

Journal Abstract Search


378 related items for PubMed ID: 33940954

  • 1. Carotid Stenosis and Recurrent Ischemic Stroke: A Post-Hoc Analysis of the POINT Trial.
    Yaghi S, de Havenon A, Rostanski S, Kvernland A, Mac Grory B, Furie KL, Kim AS, Easton JD, Johnston SC, Henninger N.
    Stroke; 2021 Jul; 52(7):2414-2417. PubMed ID: 33940954
    [Abstract] [Full Text] [Related]

  • 2. Outcomes Associated With Clopidogrel-Aspirin Use in Minor Stroke or Transient Ischemic Attack: A Pooled Analysis of Clopidogrel in High-Risk Patients With Acute Non-Disabling Cerebrovascular Events (CHANCE) and Platelet-Oriented Inhibition in New TIA and Minor Ischemic Stroke (POINT) Trials.
    Pan Y, Elm JJ, Li H, Easton JD, Wang Y, Farrant M, Meng X, Kim AS, Zhao X, Meurer WJ, Liu L, Dietrich D, Wang Y, Johnston SC.
    JAMA Neurol; 2019 Dec 01; 76(12):1466-1473. PubMed ID: 31424481
    [Abstract] [Full Text] [Related]

  • 3. Dual Antiplatelet Therapy in Transient Ischemic Attack and Minor Stroke With Different Infarction Patterns: Subgroup Analysis of the CHANCE Randomized Clinical Trial.
    Jing J, Meng X, Zhao X, Liu L, Wang A, Pan Y, Li H, Wang D, Johnston SC, Wang Y, Wang Y.
    JAMA Neurol; 2018 Jun 01; 75(6):711-719. PubMed ID: 29582084
    [Abstract] [Full Text] [Related]

  • 4. Dual Versus Mono Antiplatelet Therapy in Large Atherosclerotic Stroke.
    Kim D, Park JM, Kang K, Cho YJ, Hong KS, Lee KB, Park TH, Lee SJ, Kim JG, Han MK, Kim BJ, Lee J, Cha JK, Kim DH, Nah HW, Kim DE, Ryu WS, Kim JT, Choi KH, Choi JC, Lee BC, Yu KH, Oh MS, Kim WJ, Kwon JH, Shin DI, Sohn SI, Hong JH, Lee JS, Lee J, Gorelick PB, Bae HJ.
    Stroke; 2019 May 01; 50(5):1184-1192. PubMed ID: 30932785
    [Abstract] [Full Text] [Related]

  • 5. Treatment Effect of Clopidogrel Plus Aspirin Within 12 Hours of Acute Minor Stroke or Transient Ischemic Attack.
    Li Z, Wang Y, Zhao X, Liu L, Wang D, Wang C, Meng X, Li H, Pan Y, Wang X, Wang C, Yang X, Zhang C, Jing J, Xian Y, Johnston SC, Wang Y, CHANCE Investigators.
    J Am Heart Assoc; 2016 Mar 21; 5(3):e003038. PubMed ID: 27001965
    [Abstract] [Full Text] [Related]

  • 6. Association Between CYP2B6 Polymorphisms and Efficacy of Clopidogrel in Minor Stroke or Transient Ischemic Attack.
    Qiu X, Zhang Y, Gu H, Jiang Y, Pan Y, Jiang Y, Meng X, Wang Y, Zhao X, Li H, Wang X, Wang Y, Li Z, CHANCE Investigators.
    Stroke; 2023 Jul 21; 54(7):1770-1776. PubMed ID: 37264909
    [Abstract] [Full Text] [Related]

  • 7. Evaluation of Systolic Blood Pressure, Use of Aspirin and Clopidogrel, and Stroke Recurrence in the Platelet-Oriented Inhibition in New TIA and Minor Ischemic Stroke Trial.
    de Havenon A, Johnston SC, Easton JD, Kim AS, Sheth KN, Lansberg M, Tirschwell D, Mistry E, Yaghi S.
    JAMA Netw Open; 2021 Jun 01; 4(6):e2112551. PubMed ID: 34086033
    [Abstract] [Full Text] [Related]

  • 8. Clopidogrel plus aspirin versus aspirin alone for reducing embolisation in patients with acute symptomatic cerebral or carotid artery stenosis (CLAIR study): a randomised, open-label, blinded-endpoint trial.
    Wong KS, Chen C, Fu J, Chang HM, Suwanwela NC, Huang YN, Han Z, Tan KS, Ratanakorn D, Chollate P, Zhao Y, Koh A, Hao Q, Markus HS, CLAIR study investigators.
    Lancet Neurol; 2010 May 01; 9(5):489-97. PubMed ID: 20335070
    [Abstract] [Full Text] [Related]

  • 9. Dual Antiplatelet Therapy Using Cilostazol With Aspirin or Clopidogrel: Subanalysis of the CSPS.com Trial.
    Hoshino H, Toyoda K, Omae K, Ishida N, Uchiyama S, Kimura K, Sakai N, Okada Y, Tanaka K, Origasa H, Naritomi H, Houkin K, Yamaguchi K, Isobe M, Minematsu K, Matsumoto M, Tominaga T, Tomimoto H, Terayama Y, Yasuda S, Yamaguchi T, CSPS.com Trial Investigators.
    Stroke; 2021 Nov 01; 52(11):3430-3439. PubMed ID: 34404237
    [Abstract] [Full Text] [Related]

  • 10. Duration of Benefit and Risk of Dual Antiplatelet Therapy up to 72 Hours After Mild Ischemic Stroke and Transient Ischemic Attack.
    Guan L, Han S, Johnston SC, Bath PM, Amarenco P, Yang Y, Wang T, Jing J, Wang C, Gao Y, Chen W, Yan H, Wang X, Wang Y, Wang Y, Pan Y.
    Neurology; 2024 Oct 08; 103(7):e209845. PubMed ID: 39270151
    [Abstract] [Full Text] [Related]

  • 11. Risk for Major Hemorrhages in Patients Receiving Clopidogrel and Aspirin Compared With Aspirin Alone After Transient Ischemic Attack or Minor Ischemic Stroke: A Secondary Analysis of the POINT Randomized Clinical Trial.
    Tillman H, Johnston SC, Farrant M, Barsan W, Elm JJ, Kim AS, Lindblad AS, Palesch YY, Easton JD.
    JAMA Neurol; 2019 Jul 01; 76(7):774-782. PubMed ID: 31034032
    [Abstract] [Full Text] [Related]

  • 12. Ipsilateral Nonstenotic Carotid Disease in Minor Ischemic Stroke: an Exploratory Analysis of The POINT Randomized Clinical Trial.
    Bulwa Z, Saleh Velez FG, Brorson JR, Pinto CB.
    J Stroke Cerebrovasc Dis; 2020 Nov 01; 29(11):105115. PubMed ID: 33066893
    [Abstract] [Full Text] [Related]

  • 13. Infarct on Brain Imaging, Subsequent Ischemic Stroke, and Clopidogrel-Aspirin Efficacy: A Post Hoc Analysis of a Randomized Clinical Trial.
    Rostanski SK, Kvernland A, Liberman AL, de Havenon A, Henninger N, Mac Grory B, Kim AS, Easton JD, Johnston SC, Yaghi S.
    JAMA Neurol; 2022 Mar 01; 79(3):244-250. PubMed ID: 35040913
    [Abstract] [Full Text] [Related]

  • 14. Disability After Minor Stroke and Transient Ischemic Attack in the POINT Trial.
    Cucchiara B, Elm J, Easton JD, Coutts SB, Willey JZ, Biros MH, Ross MA, Johnston SC.
    Stroke; 2020 Mar 01; 51(3):792-799. PubMed ID: 32078486
    [Abstract] [Full Text] [Related]

  • 15. Effectiveness and safety of high dose clopidogrel plus aspirin in ischemic stroke patients with the single CYP2C19 loss-of-function allele: a randomized trial.
    Wu H, Song H, Dou L, Gao B, Pan Y, Dong M, Chen Q, Li J, Song L, Liu C, Li B, Chu W.
    BMC Neurol; 2020 Oct 29; 20(1):395. PubMed ID: 33121452
    [Abstract] [Full Text] [Related]

  • 16. Dual antiplatelet therapy with clopidogrel and aspirin in symptomatic carotid stenosis evaluated using doppler embolic signal detection: the Clopidogrel and Aspirin for Reduction of Emboli in Symptomatic Carotid Stenosis (CARESS) trial.
    Markus HS, Droste DW, Kaps M, Larrue V, Lees KR, Siebler M, Ringelstein EB.
    Circulation; 2005 May 03; 111(17):2233-40. PubMed ID: 15851601
    [Abstract] [Full Text] [Related]

  • 17. The curative effect comparison of two kinds of therapeutic regimens on decreasing the relative intensity of microembolic signal in CLAIR trial.
    Deng QQ, Tang J, Chen C, Markus H, Huang YN, Zhao H, Ratanakorn D, Wong KS, Fu JH.
    J Neurol Sci; 2016 Aug 15; 367():18-21. PubMed ID: 27423556
    [Abstract] [Full Text] [Related]

  • 18. The influence of mean arterial pressure on the efficacy and safety of dual antiplatelet therapy in minor stroke or transient ischemic attack patients.
    Ma Y, Liu Y, Xu J, Wang Y, Du F, Wang Y.
    J Clin Hypertens (Greenwich); 2019 May 15; 21(5):598-604. PubMed ID: 30957391
    [Abstract] [Full Text] [Related]

  • 19. Ticagrelor Added to Aspirin in Acute Nonsevere Ischemic Stroke or Transient Ischemic Attack of Atherosclerotic Origin.
    Amarenco P, Denison H, Evans SR, Himmelmann A, James S, Knutsson M, Ladenvall P, Molina CA, Wang Y, Johnston SC, THALES Steering Committee and Investigators*.
    Stroke; 2020 Dec 15; 51(12):3504-3513. PubMed ID: 33198608
    [Abstract] [Full Text] [Related]

  • 20. Time Course for Benefit and Risk of Clopidogrel and Aspirin After Acute Transient Ischemic Attack and Minor Ischemic Stroke.
    Johnston SC, Elm JJ, Easton JD, Farrant M, Barsan WG, Kim AS, Lindblad AS, Palesch YY, Zurita KG, Albers GW, Cucchiara BL, Kleindorfer DO, Lutsep HL, Pearson C, Sethi P, Vora N, POINT and Neurological Emergencies Treatment Trials Network Investigators.
    Circulation; 2019 Aug 20; 140(8):658-664. PubMed ID: 31238700
    [Abstract] [Full Text] [Related]


    Page: [Next] [New Search]
    of 19.